Literature DB >> 32273014

Pathogenesis and tissue tropism of natural field recombinants of infectious laryngotracheitis virus.

Dulari S Thilakarathne1, Amir H Noormohammadi2, Glenn F Browning3, José A Quinteros3, Gregory J Underwood4, Carol A Hartley3, Mauricio Jc Coppo3, Joanne M Devlin3, Andrés Diaz-Méndez3.   

Abstract

Infectious laryngotracheitis virus (ILTV) is an economically significant respiratory pathogen of poultry. Novel recombinant strains of ILTV have emerged in Australia during the last decade and currently class 9 (CL9) and class 10 (CL10) ILTV are the most prevalent circulating strains. This study conducted a comprehensive investigation of the pathogenesis of these two viral strains. Commercial broiler and specific pathogen free (SPF) chickens were inoculated with varying doses of CL9 or CL10 ILTV and subsequently evaluated for clinical and pathological signs of infection. While no difference in the levels of acute viral replication were observed across the different challenge doses, the severity of clinical signs, tracheal pathology and mortality were dose dependent. Both strains of virus persisted in the respiratory tract for up to 14 days post inoculation (dpi) and could be detected in the lung and feathers with sporadic detection in the liver, spleen or bursa. Given the prevalence of CL9 and CL10 in Australian poultry flocks, this study provides an important foundation for the development of diagnostic and therapeutic approaches for the detection and prevention of ILTV.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ILTV; Natural field recombinants; Pathogenesis; Tissue tropism

Year:  2020        PMID: 32273014     DOI: 10.1016/j.vetmic.2020.108635

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  3 in total

1.  Evaluation of Recombinant Herpesvirus of Turkey Laryngotracheitis (rHVT-LT) Vaccine against Genotype VI Canadian Wild-Type Infectious Laryngotracheitis Virus (ILTV) Infection.

Authors:  Catalina Barboza-Solis; Shahnas M Najimudeen; Ana Perez-Contreras; Ahmed Ali; Tomy Joseph; Robin King; Madhu Ravi; Delores Peters; Kevin Fonseca; Carl A Gagnon; Frank van der Meer; Mohamed Faizal Abdul-Careem
Journal:  Vaccines (Basel)       Date:  2021-12-03

2.  Pathogenicity and vaccine efficacy of two virulent infectious laryngotracheitis virus strains in Egypt.

Authors:  Mohamed El-Saied; Magdy M El-Mahdy; Mahmoud Bayoumi; Reem A Soliman; Marwa F Elsayed; Ezz El-Din Sakr; Mostafa Bastami; Munir M El-Safty; Mohamed Shaalan
Journal:  BMC Vet Res       Date:  2022-09-26       Impact factor: 2.792

3.  Recombinant Fowlpox Virus Expressing gB Gene from Predominantly Epidemic Infectious Larygnotracheitis Virus Strain Demonstrates Better Immune Protection in SPF Chickens.

Authors:  Sujuan Chen; Nuo Xu; Lei Ta; Shi Li; Xiang Su; Jing Xue; Yinping Du; Tao Qin; Daxin Peng
Journal:  Vaccines (Basel)       Date:  2020-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.